Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Burkina Faso has been showing promising growth in recent years.
Customer preferences: Burkina Faso has a high demand for vaccines due to its high prevalence of infectious diseases. The government has been actively promoting vaccination campaigns, which has increased the demand for other vaccines in the country. In addition, there is a growing awareness among the population about the importance of preventive healthcare, which has further fueled the demand for vaccines.
Trends in the market: The Other Vaccines market in Burkina Faso has been growing steadily in recent years. This growth can be attributed to several factors. First, the government has been investing heavily in the healthcare sector, which has led to an increase in the availability of vaccines. Second, there has been a growing demand for vaccines due to the high prevalence of infectious diseases in the country. Finally, there has been a growing awareness among the population about the importance of preventive healthcare, which has led to an increase in the demand for vaccines.
Local special circumstances: Burkina Faso is a landlocked country in West Africa with a population of over 20 million people. The country is one of the poorest in the world, with a GDP per capita of less than $700. The healthcare system in Burkina Faso is underdeveloped, and there is a shortage of healthcare professionals, including doctors and nurses. In addition, the country has a high prevalence of infectious diseases, including malaria, yellow fever, and meningitis.
Underlying macroeconomic factors: Burkina Faso is one of the fastest-growing economies in West Africa, with an average annual growth rate of around 6% in recent years. The government has been investing heavily in infrastructure development, including healthcare facilities, which has led to an increase in the availability of vaccines. In addition, the country has a young population, with over 60% of the population under the age of 25. This demographic trend has led to a growing demand for healthcare services, including vaccines. Finally, the government has been implementing policies to promote the healthcare sector, which has led to an increase in the demand for vaccines in the country.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
